Hoth Therapeutics, Inc is a biotechnology business based in the US. Hoth Therapeutics shares (HOTH) are listed on the NASDAQ and all prices are listed in US Dollars. Hoth Therapeutics employs 3 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Hoth Therapeutics
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – HOTH – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Hoth Therapeutics stock price (NASDAQ: HOTH)Use our graph to track the performance of HOTH stocks over time.
Hoth Therapeutics shares at a glance
|Latest market close||$1.45|
|52-week range||$1.27 - $3.50|
|50-day moving average||$1.50|
|200-day moving average||$1.82|
|Wall St. target price||$10.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.49|
Buy Hoth Therapeutics shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Hoth Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Hoth Therapeutics price performance over time
|1 week (2021-07-22)||N/A|
|1 month (2021-07-02)||-5.84%|
|3 months (2021-04-30)||-3.97%|
|6 months (2021-01-29)||N/A|
|1 year (2020-07-29)||N/A|
|2 years (2019-07-29)||N/A|
|3 years (2018-07-29)||N/A|
|5 years (2016-07-29)||N/A|
Hoth Therapeutics financials
|Gross profit TTM||$0|
|Return on assets TTM||-46.29%|
|Return on equity TTM||-77.77%|
|Market capitalisation||$32.3 million|
TTM: trailing 12 months
Shorting Hoth Therapeutics shares
There are currently 149,035 Hoth Therapeutics shares held short by investors – that's known as Hoth Therapeutics's "short interest". This figure is 14.9% down from 175,080 last month.
There are a few different ways that this level of interest in shorting Hoth Therapeutics shares can be evaluated.
Hoth Therapeutics's "short interest ratio" (SIR)
Hoth Therapeutics's "short interest ratio" (SIR) is the quantity of Hoth Therapeutics shares currently shorted divided by the average quantity of Hoth Therapeutics shares traded daily (recently around 480758.06451613). Hoth Therapeutics's SIR currently stands at 0.31. In other words for every 100,000 Hoth Therapeutics shares traded daily on the market, roughly 310 shares are currently held short.
However Hoth Therapeutics's short interest can also be evaluated against the total number of Hoth Therapeutics shares, or, against the total number of tradable Hoth Therapeutics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Hoth Therapeutics's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Hoth Therapeutics shares in existence, roughly 10 shares are currently held short) or 0.0076% of the tradable shares (for every 100,000 tradable Hoth Therapeutics shares, roughly 8 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Hoth Therapeutics.
Find out more about how you can short Hoth Therapeutics stock.
Hoth Therapeutics share dividends
We're not expecting Hoth Therapeutics to pay a dividend over the next 12 months.
Hoth Therapeutics share price volatility
Over the last 12 months, Hoth Therapeutics's shares have ranged in value from as little as $1.266 up to $3.5. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Hoth Therapeutics's is 1.0492. This would suggest that Hoth Therapeutics's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Hoth Therapeutics overview
Hoth Therapeutics, Inc. , a biopharmaceutical company, focuses on developing therapies for dermatological disorders. The company focuses on therapies for patients suffering from indications, including eczema, chronic wounds, psoriasis, asthma, and acne. Its pipeline portfolio includes HT-001, a topical formulation for the treatment of mild to moderate rash and skin disorders associated with initial and repeat courses of tyrosine kinase inhibitor/epidermal growth factor receptor (EGFR) inhibitor therapy; HT-002 to treat illness associated with SARS-CoV-2 infection; HT-003D for the topical treatment in acne and psoriasis applications; HT-003IB to treat inflammatory bowel diseases; HT-004 for the treatment of asthma, atopic dermatitis, and other allergic diseases; HT-005 Z-PODS to treat cutaneous lupus erythematosus; HT-006 for treatment of multiple bacterial pathogens. The company has license agreements with the George Washington University; the University of Maryland; Isoprene Pharmaceuticals, Inc. ; the North Carolina State University; Chelexa BioSciences, Inc. ; and the University of Cincinnati.
Stocks similar to Hoth Therapeutics
Hoth Therapeutics in the news
Hoth Therapeutics' HT-003 Shows Encouraging Action Against Acne In Animal Model
Hoth Therapeutics Announces Positive Confirmatory Results from In Vivo Model of HT-003 Assets as Potential Treatment Against Acne
Hoth Therapeutics' HT-003 Shows Encouraging Action Against Acne In Animal Model
Frequently asked questionsWhat percentage of Hoth Therapeutics is owned by insiders or institutions?
Currently 16.478% of Hoth Therapeutics shares are held by insiders and 14.676% by institutions. How many people work for Hoth Therapeutics?
Latest data suggests 3 work at Hoth Therapeutics. When does the fiscal year end for Hoth Therapeutics?
Hoth Therapeutics's fiscal year ends in December. Where is Hoth Therapeutics based?
Hoth Therapeutics's address is: 1 Rockefeller Plaza, New York, NY, United States, 10020 What is Hoth Therapeutics's ISIN number?
Hoth Therapeutics's international securities identification number is: US44148G1058 What is Hoth Therapeutics's CUSIP number?
Hoth Therapeutics's Committee on Uniform Securities Identification Procedures number is: 44148G105
More guides on Finder
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
How to buy DoubleDown Interactive (DDI) stock when it goes public
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
How to buy Omniq Corp (OMQS) stock when it goes public
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
How to buy Mechanical Technology (MKTYP) stock when it goes public
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
Ask an Expert